Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | Mr. Whitehead, age 67, served as the Chief Financial Officer... Mr. Whitehead makes valuable contributions to the Board based on his financial expertise... The current members of the Audit Committee are Caroline Loewy, Denis Burger and Warren Whitehead. Mr. Whitehead is the Chair of the Audit Committee... The following table details the compensation received by each director for the year ended December 31, 2018: Mr. Warren Whitehead 52,000 fees earned or paid in cash, 121,713 option awards, total 173,713. |
| 2020-04-24 | Mr. Whitehead, age 68, served as the Chief Financial Officer... Mr. Whitehead makes valuable contributions to the Board based on his financial expertise as a Chartered Professional Accountant (CPA)... Member of the Audit Committee... The following table details the compensation received by each non-employee director for the year ended December 31, 2019: Mr. Warren Whitehead 55,000 Fees earned or paid in cash, 51,630 Option awards, Total 106,630. |
| 2021-04-21 | Mr. Whitehead, age 69, served as the Chief Financial Officer of ProMIS Neurosciences Inc... Mr. Whitehead received this amount for his services as director on the Board and as Chair of the Board’s Audit Committee. |
| 2022-04-20 | Mr. Whitehead, age 69, serves as the Chief Financial Officer of Satellos Bioscience Inc... Mr. Whitehead received this amount for his services as director on the Board and as Chair of the Board’s Audit Committee. |
| 2023-04-19 | Mr. Whitehead earned this amount for his services as director on the Board and as Chair of the Board’s Audit Committee. |
| 2024-05-15 | Mr. Whitehead, age 71, serves as the Head of Corporate Strategy... He is Chair of the Audit Committee... Mr. Whitehead earned $80,000 for his services as director on the Board and Chair of the Audit Committee. Total compensation $122,682. |
| 2024-07-17 | Named Executive Officers and Directors Warren Whitehead 30,662 Shares beneficially owned Does not exceed one percent of Shares outstanding |
| 2024-12-30 | Name of Beneficial Owner Named Executive Officers and Directors Warren Whitehead 33,363 * |
Data sourced from SEC filings. Last updated: 2026-02-03